CP

Caligan Partners Portfolio holdings

AUM $515M
This Quarter Return
+1.19%
1 Year Return
+70.09%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$196M
AUM Growth
+$196M
Cap. Flow
+$37.8M
Cap. Flow %
19.34%
Top 10 Hldgs %
99.87%
Holding
14
New
2
Increased
3
Reduced
3
Closed
2

Top Buys

1
ALIM
Alimera Sciences, Inc.
ALIM
$50.7M
2
ANIK icon
Anika Therapeutics
ANIK
$6.73M
3
VRCA icon
Verrica Pharmaceuticals
VRCA
$1.01M
4
SCTL
Societal CDMO, Inc. Common Stock
SCTL
$288K
5
YMAB icon
Y-mAbs Therapeutics
YMAB
$127K

Top Sells

1
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
$14.3M
2
EYPT icon
EyePoint Pharmaceuticals
EYPT
$2.7M
3
LAB icon
Standard BioTools
LAB
$2.45M
4
ADMA icon
ADMA Biologics
ADMA
$895K
5
EOLS icon
Evolus
EOLS
$697K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LQDA icon
1
Liquidia Corp
LQDA
$2.38B
$58.6M 26.91%
9,243,627
– –
ALIM
2
DELISTED
Alimera Sciences, Inc.
ALIM
$52.2M 23.97%
16,835,154
+16,356,377
+3,416% +$50.7M
LAB icon
3
Standard BioTools
LAB
$481M
$22.1M 10.15%
7,622,413
-845,507
-10% -$2.45M
ANIK icon
4
Anika Therapeutics
ANIK
$135M
$20.1M 9.25%
1,081,360
+361,069
+50% +$6.73M
EXEL icon
5
Exelixis
EXEL
$10.1B
$19.9M 9.14%
910,730
– –
EOLS icon
6
Evolus
EOLS
$494M
$15.4M 7.07%
1,683,836
-76,300
-4% -$697K
VRNA
7
Verona Pharma
VRNA
$9.16B
$2.98M 1.37%
183,064
– –
ADMA icon
8
ADMA Biologics
ADMA
$4.12B
$2.14M 0.98%
597,513
-250,000
-29% -$895K
VRCA icon
9
Verrica Pharmaceuticals
VRCA
$52.8M
$1.01M 0.46%
+259,593
New +$1.01M
SCTL
10
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$794K 0.36%
1,689,768
+612,500
+57% +$288K
YMAB icon
11
Y-mAbs Therapeutics
YMAB
$388M
$127K 0.06%
+23,321
New +$127K
AGIO icon
12
Agios Pharmaceuticals
AGIO
$2.19B
$120K 0.05%
4,833
– –
EYPT icon
13
EyePoint Pharmaceuticals
EYPT
$797M
– –
-310,298
Closed -$2.7M
ICPT
14
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-1,293,510
Closed -$14.3M